Transverse Myelitis

Table of Contents

Transverse Myelitis (TM)

Transverse myelitis (TM) is a rare but serious neurological condition caused by inflammation of the spinal cord.

This inflammation leads to the formation of scars or lesions that disrupt communication between the nerves of the spinal cord and the rest of the body.

The term “transverse“ refers to the fact that the inflammation can spread across the width of the spinal cord. However, in some cases, the swelling may only affect a portion of the spinal cord’s width. TM can occur at any age and affects both children and adults.

Signs and Symptoms of Transverse Myelitis

Symptoms of transverse myelitis typically develop over a few hours to several weeks. They can vary depending on the severity and location of the inflammation. Common signs and symptoms include:

1. Motor Symptoms (Affecting Movement)

Muscle weakness in the legs, and sometimes the arms
Mobility problems, including difficulty walking or paralysis (paraplegia or quadriplegia)
Muscle spasms or involuntary muscle contractions (spasticity)

2. Sensory Symptoms (Affecting Sensation)

Tingling, numbness, or unusual sensations (burning, prickling, or coldness) in the legs, arms, or torso
Loss of sensation in affected areas
Heightened sensitivity to touch, temperature, or pain.

3. Autonomic Dysfunction (Affecting Involuntary Functions)

Bladder dysfunction (incontinence, urinary retention, or frequent urination)
Bowel dysfunction (constipation or incontinence)
Sexual dysfunction (erectile dysfunction in men, loss of sensation in women)

4. Pain Symptoms

Sharp or shooting pain in the lower back, chest, or limbs
Chronic neuropathic pain, which can persist even after inflammation subsides

In severe cases, TM can lead to complete paralysis and loss of all sensory functions below the affected area of the spinal cord.

Types of Transverse Myelitis

Transverse myelitis can be classified into different types based on how quickly symptoms develop and their duration:

1. Acute Transverse Myelitis (ATM)

The most common form of TM.
Symptoms develop suddenly, often within a few hours or days.
Can lead to rapid deterioration and may require urgent medical intervention.

2. Subacute Transverse Myelitis (STM)

Symptoms develop gradually over several weeks to months.
Less aggressive than ATM but still causes significant neurological issues.

3. Chronic Transverse Myelitis (CTM)

Symptoms persist for six months or longer.
Can lead to long-term disability due to persistent nerve damage.

Causes of Transverse Myelitis

Transverse myelitis can result from autoimmune disorders, infections, or other underlying conditions. In many cases, the exact cause remains unknown (idiopathic transverse myelitis).

1. Autoimmune Disorders

In some cases, TM is caused by an autoimmune reaction, where the immune system mistakenly attacks the body’s own nerve tissues. Autoimmune diseases that can trigger TM include:

Neuromyelitis optica (NMO) – A condition that affects both the spinal cord and optic nerves.
Myelin oligodendrocyte glycoprotein (MOG)-associated myelitis – A demyelinating disorder affecting the central nervous system.
Sarcoidosis – An inflammatory disease that can affect multiple organs, including the nervous system.
Sjögren’s syndrome – A chronic autoimmune disease affecting moisture-producing glands and sometimes the nervous system.
Systemic lupus erythematosus (lupus) – An autoimmune disease that can cause inflammation throughout the body, including the spinal cord.

2. Viral Infections

Certain viral infections can lead to TM, either directly attacking the nervous system or triggering an immune response that causes spinal cord inflammation. These include:

Enteroviruses (e.g., echovirus
Epstein-Barr virus (EBV)
Hepatitis A
Herpes simplex virus (HSV)
Human immunodeficiency virus (HIV)
Influenza virus (flu)
Rubella virus
Varicella-zoster virus (causes chickenpox and shingles)

3. Bacterial Infections

Some bacterial infections can also contribute to transverse myelitis, including:

Syphilis – A sexually transmitted infection that can affect the nervous system in its later stages.
Lyme disease – Caused by Borrelia burgdorferi bacteria transmitted through tick bites.
Tuberculosis – A bacterial infection that primarily affects the lungs but can also involve the nervous system.

4. Cancer (Paraneoplastic Syndrome)

Certain cancers may trigger an abnormal immune response, leading to inflammation of the spinal cord. This is known as paraneoplastic transverse myelitis and can occur in cancers such as:

Lung cancer
Breast cancer
Lymphomas

Diagnosing Transverse Myelitis

Diagnosis of transverse myelitis requires a combination of clinical evaluation and diagnostic tests to confirm spinal cord inflammation and rule out other conditions.

1. Neurological Examination: Assess reflexes, muscle strength, coordination, and sensory responses to determine the extent of spinal cord dysfunction.

2. Magnetic Resonance Imaging (MRI) Scan : MRI scans of the spine help identify lesions, swelling, and inflammation in the spinal cord.

MRI of the brain may be done to check for conditions like multiple sclerosis (MS) or neuromyelitis optica (NMO).

3. Lumbar Puncture (Spinal Tap): Cerebrospinal fluid (CSF) analysis can detect inflammation, infections, or autoimmune activity.

Elevated white blood cell counts or abnormal proteins may indicate infection or immune system dysfunction.

4. Blood Tests: Blood tests help detect infections, autoimmune markers, and vitamin deficiencies that might contribute to TM.

Specific antibody tests can help identify conditions like neuromyelitis optica (NMO-IgG antibody test) or MOG-associated myelitis.

5. Additional Imaging and Tests

Computed Tomography (CT) Scan – Used if MRI is unavailable or to rule out other spinal conditions.
Evoked Potential Tests – Measures how quickly nerves respond to stimulation.

Management of Transverse Myelitis (TM)

The management of transverse myelitis involves a multidisciplinary approach aimed at reducing inflammation, managing symptoms, preventing complications, and promoting functional recovery.

Aims of Management

The main objectives in managing transverse myelitis include:

Reducing inflammation in the spinal cord to minimize nerve damage.
Alleviating symptoms such as pain, muscle weakness, and bowel/bladder dysfunction.
Restoring mobility and function through rehabilitation therapies.
Preventing complications such as pressure sores, infections, and contractures.
Addressing underlying causes such as autoimmune disorders or infections.

1. Acute Phase Management (Hospital Admission and Initial Treatment)

A. Admission and Monitoring

Patients with suspected transverse myelitis are typically admitted to a hospital for close monitoring. Initial care includes:

Vital signs monitoring, especially respiratory function and cardiovascular status.
Neurological assessment to evaluate the severity and progression of symptoms.
Bladder and bowel assessment to manage dysfunctions early.

B. Medical Treatment

1. Corticosteroids (First-line Treatment)

High-dose intravenous corticosteroids (e.g., methylprednisolone) are administered to reduce inflammation and prevent further spinal cord damage.
If effective, an oral steroid taper may be given over weeks to prevent recurrence.
Side effects include increased infection risk, mood changes, stomach irritation, and weight gain.

2. Plasma Exchange Therapy (Plasmapheresis)

Used for patients who do not respond to corticosteroids.
Helps remove harmful autoantibodies from the blood.
Typically done over 5-7 sessions.

3. Immunomodulatory Therapy

For autoimmune-related TM, immunosuppressants such as azathioprine, rituximab, or cyclophosphamide may be required.

4. Antiviral or Antibiotic Therapy

If an infection (viral or bacterial) is suspected, appropriate antiviral (e.g., acyclovir) or antibiotic (e.g., ceftriaxone) treatment is given.

5. Symptomatic Treatment (Pain and Spasticity Management)

Neuropathic pain is managed with gabapentin, pregabalin, or amitriptyline.
Muscle spasms and stiffness are treated with baclofen, tizanidine, or diazepam.

2. Symptom Management and Rehabilitation

A. Managing Muscle Weakness and Mobility Issues

Muscle weakness and paralysis significantly impact mobility and independence. Treatment includes:

Physical therapy to improve muscle strength, coordination, and endurance.
Stretching and strengthening exercises to prevent contractures.
Use of mobility aids (e.g., walkers, canes, wheelchairs) for movement support.
Occupational therapy to enhance daily activities and recommend home modifications (e.g., stair lifts, grab bars).

B. Bladder Dysfunction Management

1. Overactive bladder treatment: Anticholinergic medications like oxybutynin or tolterodine.

2. Urinary retention treatment:

Intermittent self-catheterization (ISC) to empty the bladder as needed.
Indwelling catheterization for patients with severe dysfunction.
Hand-held external stimulators may help initiate urination.

C. Bowel Dysfunction Management

Constipation: High-fiber diet, increased fluid intake, and laxatives (e.g., lactulose, bisacodyl).
Severe constipation: May require suppositories or enemas.
Bowel incontinence: Pelvic floor exercises and medications like loperamide for diarrhea control.

D. Pain Management

1. Neuropathic Pain (Nerve-Related Pain) Treatment

Anticonvulsants: Gabapentin, pregabalin.
Tricyclic antidepressants: Amitriptyline, nortriptyline.

2. Musculoskeletal Pain Management

Physical therapy: Exercises, proper seating posture.
Pain relievers: NSAIDs (e.g., ibuprofen) or stronger analgesics if needed.
Transcutaneous Electrical Nerve Stimulation (TENS): May help alleviate chronic pain.

E. Sexual Dysfunction Management

Men with erectile dysfunction: PDE-5 inhibitors (e.g., sildenafil).
Women with decreased libido: Psychological counseling and sexual therapy.
Relationship counseling: Helps couples adjust to changes in intimacy.

3. Nursing Management of Transverse Myelitis

Nursing care focuses on supportive management, preventing complications, and assisting with rehabilitation.

A. Nursing Diagnoses and Interventions

Nursing Diagnosis	Interventions
Impaired physical mobility (related to muscle weakness/spasticity)	– Assist with physical therapy. – Provide mobility aids. – Prevent contractures with passive ROM exercises.
Risk for skin breakdown (due to immobility and pressure ulcers)	– Reposition every 2 hours. – Use pressure-relieving mattresses. – Keep skin dry and moisturized.
Urinary retention/incontinence	– Assist with catheterization. – Monitor fluid intake. – Teach bladder training techniques.
Bowel incontinence or constipation	– Encourage high-fiber diet and hydration. – Assist with bowel training.
Chronic pain (related to nerve damage)	– Administer prescribed analgesics. – Provide warm compresses or TENS therapy.
Risk for infection (due to catheterization, immunosuppressants)	– Follow aseptic techniques. – Monitor for fever and signs of infection.

B. Psychological and Emotional Support

Patients with TM may experience anxiety, depression, and frustration due to mobility loss.
Counseling and mental health support can help cope with emotional challenges.
Support groups allow patients to connect with others facing similar challenges.

4. Preventing Complications

Complications of transverse myelitis can be serious and life-threatening. Preventative strategies include:

Complication	Prevention Strategies
Pressure ulcers	Regular repositioning, skin assessments, pressure-relieving mattresses.
Deep vein thrombosis (DVT)	Compression stockings, anticoagulants, leg exercises.
Urinary tract infections (UTIs)	Proper catheter care, increased hydration, bladder training.
Respiratory failure	Respiratory exercises, mechanical ventilation if needed.
Chronic pain	Early pain management, physiotherapy, psychological counseling.